The present results showed that JNK activation in pancreatic cancer cell lines was increased as compared with the control cell line, HPNE (Figure 5A), and C66 markedly inhibited JNK phosphorylation in PANC-1 and SW1990 in a dose-dependent manner (Figure 5B,C). This evidence concerns the gene MAPK8 and pancreatic neoplasm.